It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
you're becoming pathetic
I can ignore you as surely as I can ignore Phage.
originally posted by: puzzled2
a reply to: Phage
People die with and without the treatment
So while you stand there wondering what to do with you hands in your pockets. waiting for the FDA to call and tell you...
They try something - it works, try it again it works again repeat and build up the information gather the information.
As asabuvsobelow said it is individualized treatments so risks or known issues will be taken in to consideration.
80% don't have symptoms
12% have mild
8% end up in hospital.
Over s 1200+ trials are being done based on people trying and having a success and replicating it.
You can't wait for an idea to form, get funding, get a trial going and do the analysis then sell the result to the most interested party during a pandemic.
To many people will die. I assume you don't want that but do you have an alternative to an extended lock downs or trying treatments?
Me - Try the treatment - try the mask, Try the face goggles, try the herd immunity but don't expect a wonder new drug any time soon.
originally posted by: TheRedneck
a reply to: themove1904
And I'd like to second that post.
TheRedneck
Speaking of translations, have you worked out how to get your browser to decode French yet?
That reporter used real experts to answer some of your questions
the Tribunal of Commerce in Lille announced that the paper would become the property of Jean-Pierre Brunois, a real-estate developer, and Olivier Rey, a former journalist for the paper.[10] The tribunal had been overseeing the bankruptcy and bids for take over since October 2005, at which point the circulation had dropped to around 50,000. The decision lead to strike by the staff who were displeased with Brunois' plan to cut costs by firing many, and increase circulation by turning the paper into a tabloid. One of the opposing bids, favored by the staff, was from Arkadi Gaydamak, the owner of The Moscow News,
Gold has been a regular on the right-wing media circuit during the pandemic, appearing on Fox News on May 21, arguing that patients are being harmed by the shutdowns taking place across the country.
Gold also appeared on PragerU’s YouTube channel back in May, insisting that more people will die from the lockdowns than from the coronavirus pandemic, and has done YouTube videos for the Tea Party Patriots Foundation, the nonprofit co-founded by Jenny Beth Martin. (Gizmodo reached out to Simone Gold for comment.)
Gold, who appears to be a co-organiser of the Beverly Hills Conservative Club
Associate Professor Julian Elliott, Executive Director of the National COVID-19 Clinical Evidence Taskforce, said the evidence indicates hydroxychloroquine is potentially harmful and no more effective than standard care in treating patients with COVID-19.
‘We have reviewed all the scientific data around hydroxychloroquine and we can now say, definitively, that hydroxychloroquine should not be used as a treatment for anyone with COVID-19,’ he said.
‘There is now sufficient data for us to make a very clear and strong recommendation. In this instance, that is based on data from randomised controlled trials that enrolled nearly 6000 patients.
‘This is a substantial amount of very high-quality scientific data upon which we’ve based the recommendation.
The vast majority of evidence is from the RECOVERY trial which randomised 4716 hospitalised patients with COVID-19
Dr Shikha Parmar 9/08/2020 1:13:51 AM
But, the door remains open for prophylaxis – but only post-exposure? There is a currently approved trial to study HCQ for prophylaxis for HCW’s youtu.be... Why contradict this? The basis for prophylaxis being how we understand the virus invades human cells and how HCQ can block this. In addition rheumatologists vehemently defend the safety of HCQ for their patients with autoimmune diseases who aren’t exactly robust individuals. This write-up leaves no scope for ongoing study or use as a mere week-long course in early Covid disease in the community to treat to avert disease progression, its touted benefit by clinicians the world-over who are championing this use. All in all a premature write-up by a taskforce of primary care doctors who are not treating the most sick in whom it’s not a great drug. But who I feel should be asking questions about its possible merit in early disease in the community or in prevention.
The basis for prophylaxis being how we understand the virus invades human cells and how HCQ can block this.
www.dw.com...
The researchers decided to conduct their experiments on a human lung cell line called Calu-3 to find out whether chloroquine has the same inhibitory effect here. After all, the novel coronavirus mainly finds its way into the human body via the lungs.
"The virus docks on the cell in the lung, is then activated by the protease TMPRSS2 and can thus enter the cell," explains Hoffmann. While chloroquine shows an inhibitory effect in the monkey cell model, it has no effect on the protease in human lung cells. "Here, it was shown that chloroquine does not prevent the virus from entering the cells," said Pöhlmann.
It's like a screaming baby on an airplane... you try to ignore, but the brat